DarioHealth (DRIO) Competitors $0.44 -0.01 (-2.67%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DRIO vs. FONR, HYPR, NVNO, APYX, VANI, NTRB, TELA, LUNG, SPAI, and CTSOShould you be buying DarioHealth stock or one of its competitors? The main competitors of DarioHealth include Fonar (FONR), Hyperfine (HYPR), enVVeno Medical (NVNO), Apyx Medical (APYX), Vivani Medical (VANI), Nutriband (NTRB), TELA Bio (TELA), Pulmonx (LUNG), Safe Pro Group (SPAI), and Cytosorbents (CTSO). These companies are all part of the "medical equipment" industry. DarioHealth vs. Its Competitors Fonar Hyperfine enVVeno Medical Apyx Medical Vivani Medical Nutriband TELA Bio Pulmonx Safe Pro Group Cytosorbents Fonar (NASDAQ:FONR) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends. Which has higher valuation & earnings, FONR or DRIO? Fonar has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than Fonar, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFonar$102.88M0.91$10.57M$1.2512.14DarioHealth$27.15M0.73-$42.75M-$0.66-0.66 Is FONR or DRIO more profitable? Fonar has a net margin of 8.19% compared to DarioHealth's net margin of -162.73%. Fonar's return on equity of 5.31% beat DarioHealth's return on equity.Company Net Margins Return on Equity Return on Assets Fonar8.19% 5.31% 3.97% DarioHealth -162.73%-65.89%-39.03% Do analysts recommend FONR or DRIO? DarioHealth has a consensus target price of $2.00, indicating a potential upside of 358.93%. Given DarioHealth's stronger consensus rating and higher possible upside, analysts plainly believe DarioHealth is more favorable than Fonar.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fonar 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00DarioHealth 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do insiders and institutionals believe in FONR or DRIO? 50.6% of Fonar shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 1.6% of Fonar shares are owned by insiders. Comparatively, 11.2% of DarioHealth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, FONR or DRIO? Fonar has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500. Does the media prefer FONR or DRIO? In the previous week, DarioHealth had 7 more articles in the media than Fonar. MarketBeat recorded 9 mentions for DarioHealth and 2 mentions for Fonar. Fonar's average media sentiment score of 1.28 beat DarioHealth's score of -0.29 indicating that Fonar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fonar 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DarioHealth 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryFonar beats DarioHealth on 10 of the 16 factors compared between the two stocks. Get DarioHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for DRIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DRIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRIO vs. The Competition Export to ExcelMetricDarioHealthMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.48M$7.07B$5.62B$9.84BDividend YieldN/A1.30%4.61%4.07%P/E Ratio-0.6625.4830.2925.74Price / Sales0.7373.48463.41115.83Price / CashN/A21.9738.2159.48Price / Book0.315.388.826.15Net Income-$42.75M$176.29M$3.25B$265.06M7 Day Performance-16.99%3.76%4.05%2.80%1 Month Performance-37.74%-0.66%4.32%1.68%1 Year Performance-51.58%12.98%36.25%29.59% DarioHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRIODarioHealth1.4778 of 5 stars$0.44-3.2%$2.00+358.9%-50.8%$20.48M$27.15M-0.66200News CoverageGap DownFONRFonar2.466 of 5 stars$15.20-1.4%N/A-7.6%$95.60M$102.88M12.16480News CoverageHYPRHyperfine1.8669 of 5 stars$1.30+12.1%$1.06-18.5%+21.0%$90.29M$12.89M-2.41190Trending NewsEarnings ReportAnalyst ForecastNVNOenVVeno Medical0.8484 of 5 stars$4.52-2.6%N/A-8.4%$89.31MN/A-3.7730APYXApyx Medical1.8419 of 5 stars$2.23+2.3%N/A+113.6%$82.45M$48.10M-4.96270Earnings ReportVANIVivani Medical2.6372 of 5 stars$1.26-8.7%$4.00+217.5%+8.6%$81.76MN/A-2.9320News CoverageEarnings ReportGap DownNTRBNutriband3.2538 of 5 stars$6.85-4.5%$13.00+89.8%+13.7%$79.97M$2.14M-7.6110Short Interest ↓TELATELA Bio2.736 of 5 stars$1.86+8.1%$7.25+289.8%-52.6%$68.04M$69.30M-1.32120Earnings ReportGap UpHigh Trading VolumeLUNGPulmonx4.261 of 5 stars$1.55flat$7.66+394.5%-73.4%$63.16M$83.79M-1.08250SPAISafe Pro Group0.8806 of 5 stars$3.86-6.8%$8.00+107.3%N/A$62.81M$2.17M-4.7711Earnings ReportCTSOCytosorbents2.1079 of 5 stars$1.20+20.0%$5.50+358.3%+20.7%$62.76M$35.60M-7.06220News CoverageEarnings ReportGap Down Related Companies and Tools Related Companies FONR Alternatives HYPR Alternatives NVNO Alternatives APYX Alternatives VANI Alternatives NTRB Alternatives TELA Alternatives LUNG Alternatives SPAI Alternatives CTSO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DRIO) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DarioHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DarioHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access